Chemoinformaics analysis of Dotriacontanoic acid
| Molecular Weight | 480.862 | nRot | 30 |
| Heavy Atom Molecular Weight | 416.35 | nRig | 6 |
| Exact Molecular Weight | 480.491 | nRing | 0 |
| Solubility: LogS | -1.29 | nHRing | 0 |
| Solubility: LogP | 1.113 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 97.7188 |
| nHD | 1 | BPOL | 65.0732 |
| QED | 0.477 |
| Synth | 3.02 |
| Natural Product Likeliness | 2.003 |
| NR-PPAR-gamma | 0.754 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.064 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.346 |
| MDCK | 0.00009 |
| BBB | 0.99 |
| PPB | 0.321672 |
| VDSS | 0.691 |
| FU | 0.632952 |
| CYP1A2-inh | 0.079 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.453 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.751 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.442 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.268 |
| CL | 10.446 |
| T12 | 0.817 |
| hERG | 0.009 |
| Ames | 0.062 |
| ROA | 0.016 |
| SkinSen | 0.587 |
| Carcinogencity | 0.799 |
| EI | 0.909 |
| Respiratory | 0.091 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.624666 |